Hexagon Interim Report 1 January

The company reported first-quarter 2026 operating net sales of 963.8 MEUR, up slightly from 961.5 MEUR, with 8% organic growth and recurring revenue of 289.9 MEUR, 6% organic. Adjusted EBIT was 251.3 MEUR versus 248.7 MEUR a year ago, while adjusted EPS rose to 6.7 euro cent from 6.5 and cash conversion improved to 77% from 60. The results are solid and modestly positive, though gross margin softened to 62.9% from 64.4%.

Analysis

The quality signal here is not top-line growth; it is the combination of stable margin and much better cash conversion. That usually tells you pricing and mix held up better than the market expected, and the working-capital unwind may be masking even stronger underlying free cash flow generation into the next quarter. If that dynamic persists, the market should start valuing the business more like a cash compounder than a simple revenue grower, which can matter a lot in a risk-off tape.

The main second-order winner is likely the company’s own capital allocation flexibility: stronger conversion expands room for buybacks, bolt-on M&A, or debt paydown without needing incremental revenue acceleration. Competitively, that pressures smaller peers that rely on growth to justify valuation while still burning cash; if this business can sustain low-to-mid-60s gross margin equivalents while growing organically, it raises the bar for rivals on both scale and operating discipline. The recurring revenue decline versus broader sales also suggests the market may be underestimating mix shifts toward less predictable project or usage revenue, which can create a later-year earnings air pocket if renewal/retention trends soften.

The key risk is that the current quarter may be benefiting from timing rather than durable demand, so the next 1-2 quarters are the critical test. If recurring revenue keeps shrinking while reported growth remains strong, investors will eventually discount the quality of earnings and compress the multiple despite headline beats. Conversely, if cash conversion stays above ~70% and gross margin holds near current levels, the stock could rerate over 3-6 months even without a material estimate raise because FCF visibility tends to re-anchor valuation faster than EPS alone.

Consensus may be focusing too much on the modest earnings beat and not enough on the cash signal. In this type of setup, the biggest upside often comes from a sustained capital return story rather than another incremental operating beat. The overlooked bear case is that a few more quarters of recurring revenue erosion can turn today’s stability into tomorrow’s growth scare, and that usually hits multiple first, not earnings.

Key Decisions for Investors

• Long the company on any 3-5% post-print pullback if management confirms cash conversion remains >70%: target a 10-15% 3-month re-rating as FCF visibility improves; stop out on any guide-down in recurring revenue.
• If liquid peers are available, put on a pair trade: long this name / short a higher-multiple competitor with weaker cash conversion for 1-2 quarters. The spread should work if investors rotate toward balance-sheet quality and free cash flow.
• Buy short-dated call spreads into the next earnings cycle only if management commentary suggests recurring revenue stabilization. Risk/reward is attractive for a 2-3 month momentum trade, but not if the mix headwind persists.
• If you own it already, consider taking partial profits into strength unless there is explicit evidence of pipeline acceleration. The market will likely reward cash flow first, but punish any sign that revenue quality is deteriorating.